左主干病变冠状动脉旁路移植术的当代结局
该研究通过倾向性匹配分析比较SYNTAX与EXCEL试验中随机接受CABG的左主干病变患者,共纳入909例(EXCEL 580例,SYNTAX 329例),EXCEL组3年主要复合终点(全因死亡、心肌梗死、卒中或缺血驱动血运重建)发生率为14.0%,低于SYNTAX组的20.9%(P=0.008)。
要点
- 左主干病变CABG术后3年复合终点从SYNTAX的20.9%降至EXCEL的14.0%(P=0.008)。
- EXCEL组非体外循环CABG比例更高(29.6% vs 15.4%,P<0.001)。
- 除心肌梗死外,全因死亡、卒中及缺血驱动血运重建均倾向于在EXCEL组更低。
核心结论
- 在5至7年期间,左主干病变外科血运重建后3年无事件生存率在SYNTAX与EXCEL试验之间显著改善,与心脏外科结局随时间改善一致。
研究设计与样本
- 对SYNTAX试验(入组2005-2007年)和EXCEL试验(入组2010-2014年)中随机接受CABG的患者进行倾向性匹配分析。
- 所有患者均有左主干病变伴或不伴多支血管病变。
- 基于15个临床和血管造影变量(包括解剖SYNTAX评分)进行调整,EXCEL与SYNTAX按2:1比例匹配,共分析909例(分别为580例和329例)。
主要发现
- 两组基线特征、解剖SYNTAX评分、移植血管数量与类型及住院时间相似。
- EXCEL组CABG更常采用非体外循环(29.6% vs 15.4%,P<0.001),且指南导向药物治疗使用更频繁。
- 主要终点(3年全因死亡、心肌梗死、卒中或缺血驱动血运重建复合)在EXCEL组为14.0%,SYNTAX组为20.9%(P=0.008)。
- 除心肌梗死(4.1% vs 3.7%)外,全因死亡(5.5% vs 8.5%)、卒中(3.1% vs 5.1%)和缺血驱动血运重建(7.1% vs 9.4%)均倾向于在EXCEL组更低。
临床怎么用
- 左主干病变患者接受CABG时,可预期3年复合终点事件率约14.0%,优于既往SYNTAX试验时代的20.9%。
- EXCEL组中非体外循环CABG和指南导向药物治疗使用更频繁,可能与结局改善相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although results of percutaneous coronary intervention (PCI) have been steadily improving, whether surgical outcomes have improved over time is not fully elucidated. OBJECTIVES: This study sought to compare the current outcomes of patients undergoing coronary artery bypass grafting (CABG) with prior surgical results, in the context of randomized trials including the left main (LM) coronary artery stem. METHODS: The authors performed a propensity-matched analysis of patients randomized to CABG in the SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) (enrollment period 2005 to 2007) and EXCEL (Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) (enrollment period 2010 to 2014) trials. All patients had left main (LM) disease with or without multivessel disease. Adjustment was based on 15 clinical and angiographic variables, including anatomic SYNTAX score, with a 2:1 ratio for the EXCEL and SYNTAX trials, collectively analyzing 909 subjects (n = 580 and n = 329, respectively). The primary endpoint was the composite of all-cause death, myocardial infarction (MI), stroke, or ischemia-driven revascularization at 3 years. RESULTS: Baseline characteristics, anatomic SYNTAX score, number and types of grafts, and duration of hospitalization for the procedures were similar in both groups. CABG procedures in the EXCEL compared with the SYNTAX trial were more often off-pump (29.6% vs. 15.4%; p < 0.001), and guideline-directed medical therapies were used more frequently in the EXCEL surgical cohort. The primary endpoint occurred in 14.0% and 20.9% (p = 0.008) of patients in the EXCEL and SYNTAX trials, respectively. With the exception of MI (4.1% vs. 3.7%), all nonhierarchical events tended to contribute to the improved outcomes in the more recent trial: all-cause death (5.5% vs. 8.5%), stroke (3.1% vs. 5.1%), and ischemia-driven revascularization (7.1% vs. 9.4%) in the EXCEL and SYNTAX trials, respectively. CONCLUSIONS: Over a 5- to 7-year period, significant improvement in event-free survival after surgical revascularization for LM disease at 3 years was noted between the SYNTAX and EXCEL trials, consistent with improving results with cardiac surgery over time. (Synergy Between PCI With Taxus and Cardiac Surgery [SYNTAX]; NCT00114972; Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization [EXCEL]; NCT01205776).
引用
- Modolo R, Chichareon P, Kogame N, et al. Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease. J Am Coll Cardiol. 2019. PMID: 30999989. doi:10.1016/j.jacc.2018.12.090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。